Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

TherapeuticsMD Inc Announces Pricing Of Public Offering Of Common Stock


Friday, 15 Mar 2013 07:00am EDT 

TherapeuticsMD Inc announced the pricing of previously announced underwritten public offering of 29,411,765 shares of common stock, offered at a price of $1.70 per share to the public. The gross proceeds to TherapeuticsMD from this offering are expected to be approximately $50.0 million, before deducting underwriting discounts, commissions, and other estimated offering expenses payable by TherapeuticsMD. All of the shares in the offering are to be sold by TherapeuticsMD. The offering is expected to close on or about March 20, 2013. TherapeuticsMD has granted the underwriters a 30-day option to purchase up to an aggregate of 4,411,765 additional shares of common stock to cover over-allotments, if any. Jefferies LLC acted as sole book-running manager for the offering, and Noble Financial Capital Markets acted as co-manager. 

Company Quote

5.36
0.01 +0.19%
20 Aug 2014